Novavax's total assets for Q4 2024 were $1.56B, a decrease of -8.88% from the previous quarter. NVAX total liabilities were $2.18B for the fiscal quarter, a -2.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.